Page last updated: 2024-08-17

levodopa and 3,4-dihydroxyphenylglycol

levodopa has been researched along with 3,4-dihydroxyphenylglycol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG1
Edwards, DJ; Rizk, M1
Edwards, DJ; Rizk, M; Spiker, DG1
Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ1
Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV1
Forsberg, M; Gogos, JA; Huotari, M; Hyttinen, J; Karayiorgou, M; Koponen, O; Männistö, PT; Raasmaja, A1
Goldstein, DS; Holmes, C; Sharabi, Y1

Other Studies

7 other study(ies) available for levodopa and 3,4-dihydroxyphenylglycol

ArticleYear
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards.
    Clinical chemistry, 1978, Volume: 24, Issue:11

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic

1978
Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
    Journal of neurochemistry, 1981, Volume: 36, Issue:5

    Topics: 3-Methoxy-4-hydroxyphenylethanol; Animals; Brain; Deuterium; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenylethyl Alcohol; Rats

1981
Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.
    Biochemical medicine, 1981, Volume: 25, Issue:2

    Topics: 3-Methoxy-4-hydroxyphenylethanol; Amines; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Phenylethyl Alcohol; Rats

1981
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
    Neurology, 1996, Volume: 46, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline

1996
Cardiac sympathetic denervation in Parkinson disease.
    Annals of internal medicine, 2000, Sep-05, Volume: 133, Issue:5

    Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver

2000
Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.
    The European journal of neuroscience, 2002, Volume: 15, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Carbidopa; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Dopamine Agents; Female; Homovanillic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Methyldopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Norepinephrine

2002
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve

2012